Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
ContributorsCusini, Alexia; Vernazza, Pietro L; Yerly Ferrillo, Sabine; Decosterd, Laurent A; Ledergerber, Bruno; Fux, Christoph A; Rohrbach, Janine; Widmer, Nicolas
; Hirschel, Bernard; Gaudenz, Roman; Cavassini, Matthias; Klimkait, Thomas; Zenger, Franziska; Gutmann, Chistine; Opravil, Milos; Günthard, Huldyrich F
Published inJournal of acquired immune deficiency syndromes and human retrovirology, vol. 62, no. 1, p. 28-35
Publication date2013
Abstract
Keywords
- Adult
- Anti-Retroviral Agents/administration & dosage/pharmacokinetics
- Antiretroviral Therapy, Highly Active/methods
- Benzoxazines/administration & dosage/pharmacokinetics
- Cerebrospinal Fluid/chemistry/virology
- Female
- HIV Infections/drug therapy/virology
- HIV-1/isolation & purification
- Humans
- Lopinavir/administration & dosage/pharmacokinetics
- Male
- Middle Aged
- Oligopeptides/administration & dosage/pharmacokinetics
- Plasma/chemistry/virology
- Pyridines/administration & dosage/pharmacokinetics
- RNA, Viral/cerebrospinal fluid
- Treatment Outcome
- Viral Load
Research groups
Citation (ISO format)
CUSINI, Alexia et al. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. In: Journal of acquired immune deficiency syndromes and human retrovirology, 2013, vol. 62, n° 1, p. 28–35. doi: 10.1097/QAI.0b013e318274e2b0
Main files (1)
Article (Published version)
Identifiers
- PID : unige:74514
- DOI : 10.1097/QAI.0b013e318274e2b0
- PMID : 23018371
Journal ISSN1077-9450